Macrophage Activation Syndrome as the First Impression of Kawasaki Disease; A Case Report

被引:2
|
作者
Amiri, Ali Ahmadzadeh [1 ]
Sadeghi, Payman [1 ]
Torshizi, Mahdieh Mousavi [1 ]
机构
[1] Univ Tehran Med Sci, Dept Pediat Rheumatol, Bahrami Childrens Hosp, Tehran, Iran
来源
关键词
Children; Iran; Macrophage Activation Syndrome; Kawasaki Disease; ACUTE-PHASE; CHILDREN; HEMOPHAGOCYTOSIS; COMMON;
D O I
10.22038/ijp.2019.41877.3529
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction Macrophage activation syndrome (MAS) is a rare and life-threatening complication of Kawasaki Disease (KD) that is usually diagnosed at the same time or after KD. We report a case of MAS as the initial manifestation of KD. Case Report A previously healthy 3-year old girl was admitted to the pediatric infectious diseases ward of Bahrami Children's Hospital, Tehran, Iran. She had a 3-day history of fever and lymphadenopathy which persisted despite antibiotic therapy. Patient's general condition gradually worsened and she developed loss of consciousness. After being diagnosed with MAS based on laboratory findings, she developed mucocutaneous manifestations of KD. She responded to methylprednisolone pulse therapy, intravenous immunoglobulin and dipyridamole. The follow-up at 2 weeks and 2 months showed no abnormal findings. Conclusion MAS may manifest even before the diagnosis of KD is made. Early recognition of MAS associated with KD and prompt treatment with corticosteroids can improve the outcome.
引用
收藏
页码:10449 / 10454
页数:6
相关论文
共 50 条
  • [31] Transient Erythroblastopenia An Unusual Manifestation of Macrophage Activation Syndrome in Kawasaki Disease
    Pilania, Rakesh Kumar
    Randhawa, Manjinder Singh
    Naseem, Shano
    Suri, Deepti
    Singh, Surjit
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S842 - S843
  • [32] Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches
    Han, Seung Beom
    Lee, Soo-Young
    WORLD JOURNAL OF PEDIATRICS, 2020, 16 (06) : 566 - 574
  • [33] Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease
    Rivera-Rodriguez, Leonardo
    Pardo-Diaz, Edwin
    Moreno-Espinosa, Sarbelio
    Scheffler-Mendoza, Selma
    Ruiz-Ontiveros, Marco A.
    Martin Garrido-Garcia, Luis
    Iglesias-Amaya, Andrea
    Yamazaki-Nakashimada, Marco A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (03) : E448 - E451
  • [34] Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome?
    Muise, A
    Tallett, SE
    Silverman, ED
    PEDIATRICS, 2003, 112 (06) : E495 - E497
  • [35] Kawasaki disease with severe manifestations and macrophage activation syndrome in a pediatric patient
    Velez-Tirado, Natalia
    Lopez, Gerardo
    Mijail Chio, Ivan
    Gutierrez Hernandez, Alonso
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (06): : E676 - E678
  • [36] Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches
    Seung Beom Han
    Soo-Young Lee
    World Journal of Pediatrics, 2020, 16 : 566 - 574
  • [37] Macrophage activation syndrome in Kawasaki disease: a literature review of Korean studies
    Jeong, Dae Chul
    Lee, Soo-Young
    JOURNAL OF RHEUMATIC DISEASES, 2025, 32 (02): : 105 - 112
  • [39] Recurrent Kawasaki Disease With Kawasaki Disease Shock Syndrome: A Case Report and Literature Review
    Ip, Chong Pak
    Lei, Cheng
    Chan, Yan
    CLINICAL PEDIATRICS, 2024, 63 (11) : 1498 - 1501
  • [40] Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
    Wang, Wei
    Gong, Fangqi
    Zhu, Weihua
    Fu, Songling
    Zhang, Qing
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) : 405 - 410